Research Fellow, Colorectal SurgeryBaylor College of MedicineHouston, Texas, United States
LB101 - Phase II Open-Label Trial Of Neoadjuvant Immunotherapy (Atezolizumab) In Combination With CAPOX For Resectable Non-Metastatic pMMR Colon Cancer: NICER STUDY
Monday, May 11, 202610:29 AM - 10:36 AM ET